A New Generation of Probiotics - Psychobiotics, Their Purpose and Functions

Abstract

A review of the literature on the etiological role of the microbiome in the treatment of depressive disorders is presented based on an analysis of 98 literature sources for 2000-2020, of which 35 are domestic and 63 are foreign. Evidence is substantiated that the gut microbiome may represent a new potential target of antidepressant therapy. The emergence of a new class of probiotics (psychobiotics), as well as possible psychobiotic treatments, could be a promising strategy for improving the quality of life of people suffering from neurodegenerative diseases and developmental disorders of the nervous system.